Terran Psychedelics

Psychedelic therapeutics redesigned

United States · Founded 2019 · $9.4M raised

Employees
1–10
Founded
2019
Business Model
B2B
Total Funding
$9.4M
Last Round
$9.4M SeedOct 2019
Rounds
1

About

Terran Biosciences is a biotech platform company developing transformative therapeutics for patients with neurological and psychiatric diseases. The company holds one of the largest psychedelic patent portfolios in the industry, with over 150 patents and patent applications spanning novel forms of psilocybin, MDMA, LSD, DMT, and other compounds. Its pipeline includes TerXT (a novel prodrug combination for schizophrenia) and Phase 3 selective serotonin 2A receptor antagonists licensed from Sanofi. The company also received FDA clearance for NM-101, an AI-enabled cloud-based software platform for analyzing neuromelanin MRI scans. Founded in 2019 by Dr. Samuel Clark, MD, PhD.

Summary

Terran Psychedelics is a Legal Tech company based in United States, founded in 2019. It has raised $9.4M in total across 1 round, most recently a $9.4M Seed round in Oct 2019. Investors include Able Partners.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedOct 2019
$9.4M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Terran Psychedelics on Indexed.vc
<a href="https://indexed.vc/companies/terran-psychedelics"><img src="https://indexed.vc/api/badge/company/terran-psychedelics" alt="Terran Psychedelics on Indexed.vc" width="260" height="76" /></a>